Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a content update to the study details page.
    Difference
    0.0%
    Check dated 2026-07-23T09:21:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous v3.6.1 as the study document version. This appears to be an administrative update that does not modify core study content.
    Difference
    0.0%
    Check dated 2026-07-02T02:31:40.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.1, signaling a small build update. The study content and visible information remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-24T23:18:36.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The study record now shows recruitment is closed to new participants, and new recruitment sites (e.g., Hunan Cancer hospital 1 and University College Hospital) along with updated navigation items were added to aid readers in understanding how to join and read the study.
    Difference
    0.3%
    Check dated 2026-06-10T14:41:35.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new version of the study documentation has been issued for the record.
    Difference
    0.0%
    Check dated 2026-06-03T08:10:18.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry was added: Revision: v3.5.4, replacing the prior v3.5.3. This indicates a routine update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-05-19T23:57:58.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.